4//SEC Filing
Baker David Charles 4
Accession 0001104659-21-022185
CIK 0001824293other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 6:00 PM ET
Size
6.6 KB
Accession
0001104659-21-022185
Insider Transaction Report
Form 4
Baker David Charles
Director
Transactions
- Other
Common Stock
2021-02-12$6.40/sh+7,843$50,195→ 7,843 total - Purchase
Common Stock
2021-02-12$8.00/sh+1,000$8,000→ 8,843 total
Footnotes (1)
- [F1]Issued immediately prior to the closing of the initial public offering of the issuer's common stock in connection with the conversion of the promissory notes held by the reporting person, as disclosed in the prospectus, dated February 9, 2021, filed with the U.S. Securities and Exchange Commission on February 11, 2021, which forms a part of the Registration Statements on Form S-1 (File Nos. 333-249636 and 333-252925), originally filed on October 23, 2020, as amended.
Documents
Issuer
Vallon Pharmaceuticals, Inc.
CIK 0001824293
Entity typeother
Related Parties
1- filerCIK 0001844060
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 6:00 PM ET
- Size
- 6.6 KB